Takeda Pharmaceutical
TAK
$14.75
Share price
1.30%
Change (1 day)
-15.42%
Change (1 year)
Categories
Market capitalization of Takeda Pharmaceutical (TAK)
Market cap: $45.94 Billion
As of January 2022 Takeda Pharmaceutical has a market cap of $45.94 Billion. This makes Takeda Pharmaceutical the world's 413th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Takeda Pharmaceutical from 2008 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $46.54 B | 8.35% |
| 2021 | $42.95 B | -24.53% |
| 2020 | $56.92 B | -8.14% |
| 2019 | $61.96 B | 136.23% |
| 2018 | $26.23 B | -40.77% |
| 2017 | $44.29 B | 35.96% |
| 2016 | $32.57 B | -17.68% |
| 2015 | $39.57 B | 19.85% |
| 2014 | $33.02 B | -9.04% |
| 2013 | $36.30 B | 2.57% |
| 2012 | $35.39 B | 1.67% |
| 2011 | $34.81 B | -9.45% |
| 2010 | $38.44 B | 18.49% |
| 2009 | $32.44 B | -29.16% |
| 2008 | $45.79 B |
End of Day market cap according to different sources
On Jan 17th, 2022 the market cap of Takeda Pharmaceutical was reported to be:
$45.94 Billion
$45.94 Billion
$46.21 Billion
$46.67 Billion
$46.33 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap difference | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $441.85 B | 861.63% | 🇺🇸 USA |
 Novartis NVS | $202.56 B | 340.86% | 🇨🇭 Switzerland |
 Pfizer PFE | $308.42 B | 571.24% | 🇺🇸 USA |
 Amgen AMGN | $132.57 B | 188.52% | 🇺🇸 USA |
 Sanofi SNY | $130.37 B | 183.74% | 🇫🇷 France |
 Merck MRK | $205.56 B | 347.37% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $114.39 B | 148.97% | 🇬🇧 UK |
 Seagen
SGEN | $25.06 B | -45.44% | 🇺🇸 USA |
 Dr. Reddy's RDY | $10.51 B | -77.12% | 🇮🇳 India |